Scientists train Patients' own cells to hunt down HPV cancers
NCT ID NCT02379520
Summary
This study is testing a new treatment for cancers linked to the human papillomavirus (HPV) that have returned or not responded to standard therapies. Researchers take a patient's own immune cells, grow them in a lab, and engineer them to better recognize and attack HPV-infected cancer cells. The main goals are to find a safe dose, see how long the cells last, and check if they can help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS-RELATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.